Publications
ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas
ESGO-ESHRE-ESGE Guidelines on fertility sparing treatment of patients with gynaecological cancers
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: Pathology and molecular biology and early, advanced and recurrent disease
ESGO Vulvar cancer guidelines update 2023
ESGO/ESTRO/SIOPe Guidelines for the management of patients with vaginal cancer
ESGO/ESTRO/ESP Cervical cancer guidelines update 2023
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
ESGO/ESTRO Quality indicators of radiation therapy of cervical cancer
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial cancer
ESGO Guidelines on Peri-operative Management of Advanced Ovarian Cancer Patients Undergoing Debulking Surgery
New ESGO/ISUOG/IOTA/ESGE Consensus Statement on Pre-Operative Diagnosis of Ovarian Tumours
ESGO Quality indicators for the surgical treatment of endometrial carcinoma
ESGO-GCIG Rare Tumours Algorithms in Mobile APP
AVAILABLE IN THE APP!
- Uterine sarcomas
- Cervical adenocarcinoma
- High-Grade Endometrial & Undifferentiated Uterine Sarcoma
- Small Cell Neuroendocrine Carcinoma of the Cervix
- Borderline ovarian tumours
- Ovarian carcinoid tumour
- Ovarian small cell carcinoma
- Ovarian teratoma
- Ovarian sex cord - stromal tumours
- Ovarian germ cell tumours of the ovary
- Ovarian mucinous carcinoma
- Ovarian low-grade serous carcinoma
- Ovarian clear cell carcinoma
- Vulvar & vaginal rare tumours

ESGO Pocket Guidelines
Designed & Reviewed by Leading Experts to Advance Standards of Care and Practice
Active filters:
English
SAVE THE DATE
Next ESGO's Annual Congress
26-28 February 2026, Copenhagen, Denmark
